Literature DB >> 12664032

Prominent mental (chin) crease: a new sign of pseudoxanthoma elasticum.

Mark Lebwohl1, Eve Lebwohl, Lionel Bercovitch.   

Abstract

Pseudoxanthoma elasticum (PXE) is an inherited disease with many systemic complications. Its diagnosis can be easily overlooked. The purpose of this study was to assess a new clinical sign of PXE. A total of 47 consecutive patients with PXE were examined for mental creases and compared with 47 age-matched control patients. Photographs were evaluated by a blinded investigator. Mental creases were present in 43 of 47 patients with PXE, affected the majority of individuals in every age group, and were significantly more common than in control patients (P <.0001). Under the age of 30 years, two thirds of patients with PXE had mental creases whereas mental creases were not present in any age-matched control patients. Mental creases commonly occur in patients with PXE. In young patients they are a sensitive and highly specific physical finding of this disorder. The presence of exaggerated mental creases is, thus, a useful physical marker for PXE.

Entities:  

Mesh:

Year:  2003        PMID: 12664032     DOI: 10.1067/mjd.2003.195

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

1.  Localized Pseudoxanthoma Elasticum-like Changes on the Chin.

Authors:  Joong Sun Lee; You Chan Kim
Journal:  Ann Dermatol       Date:  2008-12-31       Impact factor: 1.444

2.  Choroidal neovascularization and angioid streaks in pseudoxanthoma elasticum.

Authors:  Melisa Nika; Cagri G Besirli
Journal:  Int J Ophthalmol       Date:  2011-08-18       Impact factor: 1.779

Review 3.  Pseudoxanthoma elasticum: a clinical, pathophysiological and genetic update including 11 novel ABCC6 mutations.

Authors:  N Chassaing; L Martin; P Calvas; M Le Bert; A Hovnanian
Journal:  J Med Genet       Date:  2005-05-13       Impact factor: 6.318

Review 4.  Pseudoxanthoma elasticum.

Authors:  Dominique P Germain
Journal:  Orphanet J Rare Dis       Date:  2017-05-10       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.